Enable Injections
Franklin
Ohio
United States
21 articles about Enable Injections
-
Enable Injections Enhances Board with Addition of Vickie Capps
11/7/2023
Enable Injections, Inc., a company developing and manufacturing the enFuse® platform of wearable drug delivery systems, is pleased to announce the appointment of Vickie Capps to the company's Board of Directors as the head of the audit committee.
-
Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
10/2/2023
Enable Injections, Inc. ("Enable") today announced that the U.S. Food and Drug Administration (FDA) has approved the EMPAVELI Injector (enFuse®) for the subcutaneous delivery of EMPAVELI® (pegcetacoplan), which is commercialized in the United States by Apellis Pharmaceuticals, Inc. for adults with paroxysmal nocturnal hemoglobinuria (PNH).
-
Enable Injections Enhances Board with Addition of Nigel Sheail
11/10/2022
Enable Injections, Inc., a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce the appointment of Nigel Sheail to the company's Board of Directors, effective October 27, 2022.
-
Enable Injections Announces $215 Million Financing
1/27/2022
Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce $215 million in Series C financing.
-
Enable Injections Announces $25 Million Credit Facility Closed with Oxford Finance
9/8/2020
Enable Injections, Inc., a company developing and manufacturing the enFuse® platform of investigational wearable infusion devices, announced it has completed a credit facility for $25 million from Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide.
-
Enable Injections Enters into Strategic Partnerships with UCB and Apellis Pharmaceuticals
11/13/2018
Patient-centric drug delivery important for treatment adherence, commercial success
-
Enable Injections' First Closing of Series B Round to Include a New Investor
10/25/2018
Financing to Accelerate Commercial Manufacturing
-
Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products
1/8/2018
The new certification verifies that across the company’s operations and manufacturing, Enable Injections’ quality system and processes meet the rigorous regulatory requirements and comprehensive reviews of ISO 13485:2016 certification for medical devices and related services
-
One of the growing areas in the medical device industry is new approaches to drug delivery. Here are the top 5 drug delivery companies that you must be aware of.
-
Enable Injections2017: BIO Introduces First Multi-Vial/Multi-Syringe Biologics Delivery System For Several Pharma Partners At BIO 2017
6/20/2017
-
Enable Injections Bags $30 Million Series A, Plans to Triple Workforce
10/6/2016
-
Enable Injections Completes Cincinnati Manufacturing Facility For On Body Delivery Systems
6/7/2016
-
Enable Injections And Flextronics Partner For Production Of Wearable High Volume Injectors
2/3/2016
-
Enable Injections Introduces Mobile Monitoring And Larger Volume Capabilities To Its Compact-Sized High Volume Wearable Injectors
10/5/2015
-
Enable Injections Introduces Mobile Monitoring And Larger Volume Capabilities To Its Compact-Sized High Volume Wearable Injectors
10/5/2015
-
Enable Injections Completes Its First-In-Human Wearable Injector Pilot Trial
9/9/2015
-
GUEST COLUMN: Enable Injections: New Body Worn Injectors Change Beliefs About Subcutaneous Drug Delivery
1/15/2015
-
Startup Enable Injections Hiring As It Inks Deal With CSL Behring
11/13/2014
-
CSL Behring Signs Strategic Development Agreement With Enable Injections To Market Novel New Drug Delivery Device
10/28/2014
-
Innovative Wearable Injector Developer, Enable Injections, Wins 'Buzz Of Biotechnology Industry Organization (BIO) Investor Forum'
9/23/2014